ClinicalTrials.gov
public full text
Public Domain
Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Electroporation therapy may enhance the ability of chemotherapy drugs to enter tumor cells. Combining chemotherapy with electroporation therapy may kill more tumor cells. PURPOSE: Randomized phase I trial to compare the effectiveness of bleomycin with or without electroporation therapy in treating patients who have stage III or stage IV melanoma.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Effect of Reduced Bleomycin in Electrochemotherapy Treatment#877368
- Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma#1163696
- Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck#912150
- Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer#840698
- Current perioperative outcomes for patients with disseminated cancer#683989
Record · ID 993550
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive